Patents Assigned to Covalent Bioscience Incorporated
  • Immunoglobulins directed to bacterial, viral and endogenous polypetides
    Patent number: 12071471
    Abstract: Disclosed are antibodies (immunoglobulins) and fragments thereof that hydrolyze or bind polypeptide antigens belonging to Staphylococcus aureus, hepatitis C virus, human immunodeficiency virus and Alzheimer's disease. Also disclosed are novel methods to improve the antigen reactivity of the immunoglobulins and to treat a pathophysiological condition using the immunoglobulins as therapeutics.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: August 27, 2024
    Assignee: COVALENT BIOSCIENCE INCORPORATED
    Inventors: Sudhir Paul, Stephanie Planque, Yasuhiro Nishiyama, Eric L. Brown, Keri C. Smith, Hiroaki Taguchi
  • Immunoglobulins directed to bacterial, viral and endogenous polypeptides
    Patent number: 9969797
    Abstract: Disclosed are antibodies (immunoglobulins) and fragments thereof that hydrolyze or bind polypeptide antigens belonging to Staphyloccus aureus, hepatitis C virus, human immunodeficiency virus and Alzheimer's disease. Also disclosed are novel methods to improve the antigen reactivity of the immunoglobulins and to treat a pathophysiological condition using the immunoglobulins as therapeutics.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: May 15, 2018
    Assignee: Covalent Bioscience Incorporated
    Inventors: Sudhir Paul, Stephanie Planque, Yasuhiro Nishiyama, Eric L. Brown, Keri C. Smith, Hiroaki Taguchi